We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Mild-to-Moderate Hypertriglyceridemia Leads to Acute Pancreatitis

By LabMedica International staff writers
Posted on 23 Nov 2016
Pancreatitis is very painful and it may lead to fatalities and until now, medical science has connected the risk of developing this illness to gallstone, a high intake of alcohol and very high concentrations of blood fats or triglycerides.

Normal levels of blood triglycerides would typically be 0-2 mmol/L, while 2-10 is classified as a mild to moderate increase. More...
If blood fat levels rise above 10 mmol/L it is considered a very high increase and previously, this was considered the risk factor to look for in relation to pancreatitis.

Clinical biochemists and their colleagues at the Copenhagen University Hospital (Herlev, Denmark) carried out a prospective cohort study examines individuals from the Copenhagen General Population Study in 2003 to 2015 and the Copenhagen City Heart Study initiated in 1976 to 1978 with follow-up examinations in 1981 to1983, 1991 to 1994, and in 2001 to 2003. Median follow-up was 6.7 years and includes 116, 550 individuals with a triglyceride measurement from the Copenhagen General Population Study and the Copenhagen City Heart Study. All individuals were followed until the occurrence of an event, death, emigration, or end of follow-up, in November 2014.

The scientists showed that even a 2 mmol/L significantly increases the risk of pancreas inflammation, and the risk is nine times higher with blood triglycerides levels at 5-10 mmol/L. Compared with individuals with plasma triglyceride levels less than 89 mg/dL (<1 mmol/L), the multivariable adjusted hazard ratios (HRs) for acute pancreatitis were 1.6; for individuals with triglyceride levels of 89 mg/dL to 176 mg/dL, HR was 2.3. The HRs increased as triglycerides incrementally until for individuals with triglyceride levels greater than or equal to 443 mg/dL (≥5.00 mmol/L), the HR reached 8.7. Corresponding HRs for myocardial infarction were followed a similar correlation.

Børge Nordestgaard, MD, DMSc, a professor and the lead investigator said, “Until now, medical science has focused primarily on high blood cholesterol, but our study shows that we should also pay attention to more common fats. Mild to moderate levels of blood fats cause a lot more diseases than we have hitherto been aware of and we need many more studies in this area. I know that currently studies are undertaken that investigate whether lowering the levels of blood fats also lowers the risk of developing cardiovascular diseases.” The study was published on November 7, 2016, in the Journal of the American Medical Association Internal Medicine.

Related Links:
Copenhagen University Hospital


Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.